TY - JOUR
T1 - Clinical course of Japanese patients with early systemic sclerosis
T2 - A multicenter, prospective, observational study
AU - Utsunomiya, Akira
AU - Hasegawa, Minoru
AU - Oyama, Noritaka
AU - Asano, Yoshihide
AU - Endo, Hirahito
AU - Fujimoto, Manabu
AU - Goto, Daisuke
AU - Ishikawa, Osamu
AU - Kawaguchi, Yasushi
AU - Kuwana, Masataka
AU - Ogawa, Fumihide
AU - Takahashi, Hiroki
AU - Tanaka, Sumiaki
AU - Sato, Shinichi
AU - Takehara, Kazuhiko
AU - Ihn, Hironobu
N1 - Funding Information:
Financial support: This work was supported by funds for research on intractable diseases from the Ministry of Health, Labor, and Welfare of Japan. The manuscript has not been previously published nor has it been submitted simultaneously for publication elsewhere. The authors are grateful to all the participated patients and physicians who have contributed in assembling the data at each facility. The aythors also thank Tomoko Hayashi and Yuko Yamada (Department of Dermatology, Kanazawa University) for their assistance in registering data.
Publisher Copyright:
© 2020 Japan College of Rheumatology.
PY - 2021
Y1 - 2021
N2 - Objectives: To investigate the clinical course of Japanese patients with early diffuse cutaneous systemic sclerosis (dcSSc) and early SSc with interstitial lung disease (ILD). Methods: We prospectively analyzed the clinical features of 207 Japanese patients with early dcSSc (n = 150) and limited cutaneous SSc (lcSSc) with ILD (n = 57) in 10 medical centers every year for 7 consecutive years. Results: Mean modified Rodnan total skin thickness score (mRSS) was 18.3 and 67.4% of the cohort had ILD. Most patients started immunosuppressive therapy and vasodilators during 7 years (83.4% and 87.9%, respectively). Mean value of mRSS of total patients was significantly reduced from the initial registration after the first year. However, other parameters for physical function associated with skin sclerosis including fist closure, hand extension, and oral aperture were not so ameliorated during the study period. Health Assessment Questionnaire-disability index and serum KL-6 levels were constant throughout the course. Percent vital capacity and the presence of ILD, clinically suspected pulmonary arterial hypertension, and digital ulcers were gradually exacerbated during the period. Conclusion: In Japanese early dcSSc patients and SSc patients with ILD, mRSS was continuously reduced during 7 years of follow-up, but there was little improvement of physical disability and organ involvement.
AB - Objectives: To investigate the clinical course of Japanese patients with early diffuse cutaneous systemic sclerosis (dcSSc) and early SSc with interstitial lung disease (ILD). Methods: We prospectively analyzed the clinical features of 207 Japanese patients with early dcSSc (n = 150) and limited cutaneous SSc (lcSSc) with ILD (n = 57) in 10 medical centers every year for 7 consecutive years. Results: Mean modified Rodnan total skin thickness score (mRSS) was 18.3 and 67.4% of the cohort had ILD. Most patients started immunosuppressive therapy and vasodilators during 7 years (83.4% and 87.9%, respectively). Mean value of mRSS of total patients was significantly reduced from the initial registration after the first year. However, other parameters for physical function associated with skin sclerosis including fist closure, hand extension, and oral aperture were not so ameliorated during the study period. Health Assessment Questionnaire-disability index and serum KL-6 levels were constant throughout the course. Percent vital capacity and the presence of ILD, clinically suspected pulmonary arterial hypertension, and digital ulcers were gradually exacerbated during the period. Conclusion: In Japanese early dcSSc patients and SSc patients with ILD, mRSS was continuously reduced during 7 years of follow-up, but there was little improvement of physical disability and organ involvement.
KW - Clinical course
KW - interstitial lung disease
KW - skin sclerosis
KW - systemic sclerosis
KW - treatment outcome
UR - http://www.scopus.com/inward/record.url?scp=85083663856&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85083663856&partnerID=8YFLogxK
U2 - 10.1080/14397595.2020.1751408
DO - 10.1080/14397595.2020.1751408
M3 - Article
C2 - 32243215
AN - SCOPUS:85083663856
SN - 1439-7595
VL - 31
SP - 162
EP - 170
JO - Japanese Journal of Rheumatology
JF - Japanese Journal of Rheumatology
IS - 1
ER -